Download
13005_2024_Article_438.pdf 1,75MB
WeightNameValue
1000 Titel
  • Bi-institutional analysis of microbiological spectrum and therapeutic management of parotid abscesses
1000 Autor/in
  1. Mayer, Marcel |
  2. Esser, Julia |
  3. Walker, Sarah Victoria |
  4. Shabli, Sami |
  5. Lechner, Axel |
  6. Canis, Martin |
  7. Klussmann, Jens Peter |
  8. Nachtsheim, Lisa |
  9. Wolber, Philipp |
1000 Verlag BioMed Central
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-07-12
1000 Erschienen in
1000 Quellenangabe
  • 20(1):38
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13005-024-00438-w |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11241904/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>A parotid abscess (PA) is a complication of an acute bacterial parotitis with a potentially life-threatening course. To date, data on the diagnosis and therapy of PA is sparse and mostly consists of case reports or case series. Therefore, this study aimed at comprehensively analyzing the microbiological spectrum and the therapeutic management in a bi-institutional setting.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>A retrospective clinical chart review was performed to identify all patients surgically treated for PA at two tertiary care centers in Germany. Data on demographics, clinical management and microbiological data including species identification, pathogenicity, type of antibiotic therapy, adjustment of antibiotics, antibiotic sensitivity testing, and smear test results were extracted. Intervention-related variables and etiology were analyzed for their statistical association with outcome variables.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>Overall, 85 patients were included. Most patients (92.9%) underwent surgical incision. Around half of the patients (45.9%) were treated under local anesthesia. No facial nerve palsy was observed. The most frequently detected pathogens were <jats:italic>Streptococci</jats:italic> (<jats:italic>n</jats:italic> = 23), followed by <jats:italic>Staphylococcus aureus</jats:italic> (<jats:italic>n</jats:italic> = 6) including one case of methicillin-resistant <jats:italic>Staphylococcus aureus</jats:italic>. Most patients (68.2%) received an aminopenicillin ± beta-lactamase inhibitor as empiric antibiotic therapy. In 6 cases the antibiotic therapy was modified after receiving the antibiogram. Four patients (5.2%) presented with recurrent PA. Etiology was idiopathic (42.4%), followed by tumorous (12.9%), obstructive, and immunosuppressive (each 11.8%). Patients with a dental focus (<jats:italic>p</jats:italic> = 0.007) had a longer duration of hospitalization.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusion</jats:title> <jats:p>The results show that the surgical therapy of PA under local anesthesia is safe. A dental examination should routinely be performed to rule out a dental focus. Obtaining a microbiological specimen in order to modify antibiotic therapy if necessary and a histopathological specimen to rule out a tumorous etiology is obligate.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Parotitis/therapy [MeSH]
lokal Aged, 80 and over [MeSH]
lokal Aged [MeSH]
lokal Parotid Diseases/microbiology [MeSH]
lokal Parotitis/microbiology [MeSH]
lokal Abscess/therapy [MeSH]
lokal Male [MeSH]
lokal Abscess/drug therapy [MeSH]
lokal Tumor
lokal Parotid abscess
lokal Microbiology
lokal Microbial Sensitivity Tests [MeSH]
lokal Adolescent [MeSH]
lokal Female [MeSH]
lokal Anti-Bacterial Agents/therapeutic use [MeSH]
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Treatment Outcome [MeSH]
lokal Pathogenicity
lokal Retrospective Studies [MeSH]
lokal Middle Aged [MeSH]
lokal Parotitis/surgery [MeSH]
lokal Research
lokal Abscess/microbiology [MeSH]
lokal Germany [MeSH]
lokal Parotid Diseases/surgery [MeSH]
lokal Young Adult [MeSH]
lokal Parotid Diseases/drug therapy [MeSH]
lokal Antibiotics
lokal Treatment strategies
lokal Sialolithiasis
lokal Abscess/surgery [MeSH]
lokal Parotitis/drug therapy [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/TWF5ZXIsIE1hcmNlbA==|https://frl.publisso.de/adhoc/uri/RXNzZXIsIEp1bGlh|https://frl.publisso.de/adhoc/uri/V2Fsa2VyLCBTYXJhaCBWaWN0b3JpYQ==|https://frl.publisso.de/adhoc/uri/U2hhYmxpLCBTYW1p|https://frl.publisso.de/adhoc/uri/TGVjaG5lciwgQXhlbA==|https://frl.publisso.de/adhoc/uri/Q2FuaXMsIE1hcnRpbg==|https://frl.publisso.de/adhoc/uri/S2x1c3NtYW5uLCBKZW5zIFBldGVy|https://frl.publisso.de/adhoc/uri/TmFjaHRzaGVpbSwgTGlzYQ==|https://frl.publisso.de/adhoc/uri/V29sYmVyLCBQaGlsaXBw
1000 Hinweis
  • DeepGreen-ID: c543ec35f1a8449aa2f4eb514e94edb8 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Universitätsklinikum Köln |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Universitätsklinikum Köln |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6518879.rdf
1000 Erstellt am 2025-07-05T14:10:16.271+0200
1000 Erstellt von 322
1000 beschreibt frl:6518879
1000 Zuletzt bearbeitet 2025-08-15T21:09:01.062+0200
1000 Objekt bearb. Fri Aug 15 21:09:01 CEST 2025
1000 Vgl. frl:6518879
1000 Oai Id
  1. oai:frl.publisso.de:frl:6518879 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source